Critical and Point-of-Care Testing: Real World and Emerging Applications for Improved Clinical Outcomes

Accepted Abstracts

Session 1: POCT and Molecular Diagnostics

1. Analytical Evaluation of Heparin Concentration in GEM® Draw Syringes
Jennifer Distasio
(PDF Slides)

2. Battery Powered DNA Testing System for POCT and Resource Limited Settings
James Lipscomb
(PDF Slides) (Graphics)

3. Evaluation of Whole Blood BUN, Creatinine and tCO2 Assays vs. Roche Modular Chemistry Analyzer
Han Chuang
(PDF Slides)

4. Evaluation of Whole Blood Creatinine and Urea Assays versus Abbott ARCHITECT c8000
Clarke Xu
(PDF Slides)

5. Hydroxocobalamin Interference with Carboxyhemoglobin (COHb) Measurements
Prasad Pamidi
(PDF Slides)

6. Point of Care PK Quantitation Device for Pharmacokinetic Guided Dosing of Paclitaxel as a Companion Diagnostic Device
Yueh Jung Lee
(PDF Slides)

7. Ultrathin Au-Pt nanowires grown on graphene sheets and their application for carcinoembryonic antigen detection
Weiping Qian
(PDF Slides)

Session 2: POCT and Infectious Disease

8. A truly hand held, rapid, sensitive electrochemical immunoassay point of care system
Courtney Nicholson
(PDF Slides)

9. Automated Flow Cyotmetry for Medical Diagnostics
Sharon Keren
(PDF Slides)(Graphics)

10. Barriers faced in the global implementation of rapid and point-of-care tests for HIV infection: a systematic review (1996-2014)
Nitika Pant Pai
(PDF Slides)

11. Can Point of Care devices performing Nucleic Acid Testing (POC NAT)
replace Real time PCR or not?

Ola Elgaddar
(PDF Slides)

12. Detection of Proviral HIV-1 DNA in Whole Blood using Recombinase Polymerase Amplification (RPA)
Brittany Rohrman
(PDF Slides)

13. Inhibitory effect on growth of moraxella catarrhalis using acetone extract of salvia pachyphylla
Maria Sanchez-Diaz
(PDF Slides) (Graphics)

14. Novel Use of POCT Devices for Diagnosis of Bacterial Infections and Sepsis in Critical Care
Jonathan Dedes
(PDF slides) (PDF Slides)

15. POCT WBC Reduces Antibiotic Prescription – A Prospective Pediatric Study
Carla Marcolin
(PDF Slides)

16. Rapid, ultrasensitive isolation of pathogenic Candida species directly from whole human blood
Lisa-Jo Clarizia
(PDF Slides) (Graphics)

17. Detection of Influenza Viruses Using a Novel Electrochemical Assay
Suri S. Iyer
(PDF Slides)

Session 3: POCT for Assessment of Coagulation

19. Assessing of the Ease of Use and Graphical User Interface Functionality of the ProTime InRhythm by Untrained Users
Soumaya El Rouby
(PDF Slides)

20. Clinical and operational benefits of INR POCT in Indigenous Communities in the Remote Northern Territory of Australia
Brooke Spaeth
(PDF Slides)

21. Clinical Validation of the ProTime InRhythm PT/INR in Professional Use Settings
Soumaya El Rouby
(PDF Slides)

22. Comparison of Point of Care Activated Clotting Time Systems in different Clinical Settings in a Large Academic Medical Center
Nichole Korpi-Steiner
(PDF Slides)

23. Comparison of the diagnostic validity of three POC D-dimer assays
Eberhard Spanuth
(PDF Slides)

24. Comparison of the INR (International Normalized Ratio) levels obtained by portable coagulometer and laboratory in a clinic specializing in oral anticoagulation
Cecilia Barroso
(PDF Slides) (Graphics)

25. Dose Response Curve Validation of a POCT Test to Measure the Effect of Antiplatelet Drugs: An Alternative Approach to Light Transmission Aggregation Validation
Jackie Coleman
(PDF Slides)

26. FDA Regulation of Point of Care Testing (POCT) Coagulation Devices
Claudia Dollins
(PDF Slides)

27. New Horizon Point-of-Care Coagulation Instrument
Claudia Campbell-Matland
(PDF Slides)

29. Results of external quality control for the COAGUCHEK XS INR point-of-care monitor using a control set with assigned values.
P. Meijer
(PDF Slides)

30. Troubleshooting HEMOCHRON® Elite Error Messages
Mary Rozmanc
(PDF Slides)

31. Using Point-Of-Care Anticoagulation Test Results to Improve Ambulatory Warfarin Management in a Large Academic Healthcare System
Hannah Poczter
(PDF Slides)

32. Verification of the Reference Range for POCT Platelet Function Testing: Evaluation of Normal Donors for the VerifyNow PRU Test
Jackie Coleman
(PDF Slides)

Session 4: POCT for Emergency Preparedness and Resource Limited Countries

33. A new point-of-care analyzer for rapid and precise determination of lipid profile and HBA1c
Bo Joergensen
(PDF Slides)

34. A survey of the awareness, knowledge and experience of point of care doctors in Nigeria
John Bolodeoku
(PDF Slides)

35. Challenges in quality management for point-of-care-testing at a tertiary hospital in a resource-limited country
Ifeyinwa Osegbe
(PDF Slides)

36. Enhancing Error Detection Capabilities in Point-of-Care Analyzer
Sohrab Mansouri
(PDF Slides)

37. Integrated Nucleic Acid Testing for TB diagnosis in Peripheral Settings: Cartridge and Instrument
Angelika Niemz
(PDF Slides)

38. Integrated Nucleic Acid Testing for TB diagnosis in Peripheral Settings: Sample Preparation, Amplification, and Detection Processes
Angelika Niemz
(PDF Slides)

39. PATHFAST Presepsin in Patients with SIRS and Early Sepsis in the Emergency Department
Eberhard Spanuth
(PDF Slides)(Graphics)

40. Saliva as a sample matrix for rapid, quantitative diagnostics in resource limited settings
Courtney Nicholson
(PDF Slides)

Session 5: Practical Applications of Point-of-Care Testing: Data Driven Solutions for Improved Outcomes

42. A study of the time and resources required in the development of an Individualized Quality Control Plan for a moderately complex test system
William Donohue
(PDF Slides)

43. A wireless, hand-held, Smartphone-based “assay agnostic” analyzer that delivers rapid, point-of-care, central laboratory quality diagnostic results using the iAssay™ platform.
Lonnie Adelman
(PDF Slides)(Graphics)

44. Application of Nova StatStrip Blood Glucose Monitoring System for monitoring hypoglycemia in Newborns
Robbert Slingerland
(PDF Slides)

45. Assessing blood glucose by glucometers may be injurious to health
Mahesh Phad
(PDF Slides) (Graphics)

46. Assessment of the Accuracy and Imprecision of the StatStrip Ketones POC Monitoring Device Compared to Central Lab Methods
Keita Yamashita
(PDF Slides)

47. Blood Glucose Measurement Traceability to a Primary Reference Measurement Procedure (IDMS); a Key Step for Evaluating POC Glucose methodologies
Marion Fokkert
(PDF Slides)

48. Blood glucose measurements in neonates: The importance of getting it right
Lisa Mackay
(PDF Slides)

49. Clinical Evaluation of a Handheld POC Creatinine Device in a Sick Diabetes Patient Setting
Fabrizio Mastrantonio
(PDF Slides)

50. Comparative Analysis of Capillary Whole Blood by Two Blood Glucose Monitoring Systems (BGMS) with Venous Plasma Hexokinase Glucose Results in Patients Undergoing an Oral Glucose Tolerance Test (OGTT)
Keita Yamashita
(PDF Slides)

51. Comparison of 3 Models for Assessing Insulin Dosing Error when a Blood Glucose Monitoring System is used in Various Patient Populations
Jeffrey DuBois
(PDF Slides)

52. Comparison of Glucose Meter Performance Against Three Reference Methods: An Extensive Evaluation
Nam Tran
(PDF Slides)

53. Comparison of Glucose Meters at Al-Adan Hospital Kuwait
Eisa Ahmad
(PDF Slides)

54. Comparison of the Nova Biomedical StatStrip Glucose Meter to an IDMS Hexokinase Glucose Method in Oncology and Renal Insufficient Patients – Demonstration of Utility in Critically Ill PatientsDavid Sartori
(PDF Slides)

55. Comparison of Umbilical Cord Whole Blood Lactate on Nova Biomedical StatStrip Lactate Meter with Gem Premier 4000 Blood Gas Analyzer and Abbott ARCHITECT ci16200 Laboratory Method
Peter Talsma
(PDF Slides)

56. Evaluation of Quantitative Cardiac Troponin POCT Devices for their Use in An Emergency Setting
Tony Avades
(PDF Slides)

57. Economic evaluation of blood glucose point–of–care testing in the intensive care unit
Marianne Mulder
(PDF Slides)

58. Evaluation of pre-hospital point of care testing for lactate in sepsis and trauma patients by enhanced care paramedics in the North East Ambulance Service
Paul Younger
(PDF Slides)

59. Evaluation of the Point-of-Care Lateral Flow Thyrotest TSH Utilizing the Holomic Android “Smartphone” Reader Versus the Centaur XP TSH: Whole Blood Versus Plasma
Kenneth Blick
(PDF Slides)

60. Extensive Evaluation of Sample Interferences on Point-of-Care Glucose Meters against an IDMS Reference Method
Nam Tran
(PDF Slides)

61. Fetal scalp lactate testing to assess fetal status during delivery
Elvira Kozak
(PDF Slides)

62. Glucose correlation between Siemens point-of-care RAPIDPoint 500 Blood Gas System and two central laboratory platforms – RAPIDLab 1265 Blood Gas System and ADVIA 1800 Clinical Chemistry System
Sheila Gavan
(PDF Slides)

63. Hormone Replacement Therapy in Light of the Cancer Profile
Emile Schandl
(PDF Slides)

64. Impact of glucose meter accuracy on the efficacy of glycemic control in critically ill patients after cardiovascular surgery
Brad Karon
(PDF Slides)

65. Introduce the Mobile Health Check Car using POCT devices in Japan
Hideo Sakamoto
(PDF Slides)

66. Investigation of Falsely Decreased Creatinine Measurements from the Abbott I-STAT POCT Device in Use for Testing Specimens from Ambulatory Oncology Patients
Stephen Kahn
(PDF Slides)

67. Investigation of Maltose Interference on the Roche ACCU-CHEK Inform II
Lu Song
(PDF Slides)

68. POCT in Action: Addressing Inpatient Glycaemic Control with an Automated Inpatient Glucometry Alert System
Fabrizio Mastrantonio
(PDF Slides) (Graphics)

69. Point of Care Measurement of Cord Blood and Fetal Scalp Lactate: Problems of Haematocrit Interference
Lisa Mackay
(PDF Slides)

70. Quantitative collection/purification and analysis of saliva analytes in a POC setting.
Robert Buck
(PDF Slides)

71. Reagentless Capability of a Comprehensive Bioelectronic Platform developed for POC diagnostics
Dimitra Georganopoulou
(PDF Slides)

72. Reduction in the number of reported results from blood gas analyzers on an Adult Intensive Care Unit by effective order management and parameter selection on the blood gas analyzer
Edmee van Dongen-Lases
(PDF Slides)

73. STATCREAT Trial - Randomized controlled trial of point of care creatinine / eGFR versus standard care to reduce Contrast Induced Nephropathy (CIN) in Primary Percutaneous Coronary Intervention (PPCI) for ST elevation Myocardial Infarction (STEMI)
Thomas Keeble
(PDF Slides)

74. The Fern Test Compared with ROM Plus® for the Detection of Amniotic Fluid in the Diagnosis of Ruptured Fetal Membranes
Linda Rogers
(PDF Slides)

76. The Use of Data Management System to Maintain a Quality Point of Care Testing Program
Debra Mason
(PDF Slides)

77. The Use of Pleural Fluid pH in POCT
Lawrence Crolla
(PDF Slides)

78. Traceability and Accuracy Evaluation of POC StatStrip Blood Glucose Monitoring System and ABL 835 Bloodgas Analyzer to a Primary IDMS aligned Reference Measurement Procedure
Marion Fokkert
(PDF Slides)

79. Troponin I Testing in the Pediatric Emergency Department in Cases of Possible Myocardial Injury
Kerstin Halverson
(PDF Slides)

80. Evaluation of a Point of Care chemistry Device for Use in Cardiopulomary Bypass and Extracorporeal Membrane Oxygenation
Sarah Brown
(PDF Slides)

Page Access: